J7639 Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Short descriptor: Dornase alfa non-comp unit
Look up J7639 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J7639 is the HCPCS Level II code for Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Special coverage instructions apply (code D)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2009-01-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- Dornase alfa, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- Route
- inhalation solution
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J7639 with the canonical source and edition:
J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J7639
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J7639